This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by de la Fuente, A. Articles by Liras, P. Search for Related Content PubMed PubMed Citation Articles by de la Fuente, A. Articles by Liras, P.

 Previous Article  |  Next Article 

Journal of Bacteriology, December 2002, p. 6559-6565, Vol. 184, No. 23
0021-9193/02/$04.00+0     DOI: 10.1128/JB.184.23.6559-6565.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Mutants of Streptomyces clavuligerus with Disruptions in Different Genes for Clavulanic Acid Biosynthesis Produce Large Amounts of Holomycin: Possible Cross-Regulation of Two Unrelated Secondary Metabolic Pathways

Area de Microbiología, Facultad de Ciencias Biológicas y Ambientales, Universidad de León, 24071 León, Spain

Received 28 June 2002/ Accepted 10 September 2002

A Streptomyces clavuligerus ccaR::aph strain, which has a disruption in the regulatory gene ccaR, does not produce cephamycin C or clavulanic acid, but does produce a bioactive compound that was identified as holomycin by high-performance liquid chromatography (HPLC) and infrared and mass spectrometry. S. clavuligerus strains with disruptions in different genes of the clavulanic acid pathway fall into three groups with respect to holomycin biosynthesis. (i) Mutants with mutations in the early steps of the pathway blocked in the gene ceaS (pyc) (encoding carboxyethylarginine synthase), bls (encoding a ß-lactam synthetase), or open reading frame 6 (ORF6; coding for an acetyltransferase of unknown function) are holomycin nonproducers. (ii) Mutants blocked in the regulatory gene ccaR or claR or blocked in the last gene of the pathway encoding clavulanic acid reductase (car) produce holomycin at higher levels than the wild-type strain. (iii) Mutants with disruption in cyp (coding for cytochrome P450), ORF12, and ORF15, genes that appear to be involved in the conversion of clavaminic acid into clavaldehyde or in secretion steps, produce up to 250-fold as much holomycin as the wild-type strain. An assay for holomycin synthetase was developed. This enzyme forms holomycin from holothin by using acetyl coenzyme A as an acetyl group donor. The holomycin synthase activities in the different clavulanic acid mutants correlate well with their production of holomycin.

This article has been cited by other articles:

• de la Fuente, A., Martin, J. F., Rodriguez-Garcia, A., Liras, P. (2004). Two Proteins with Ornithine Acetyltransferase Activity Show Different Functions in Streptomyces clavuligerus: Oat2 Modulates Clavulanic Acid Biosynthesis in Response to Arginine. J. Bacteriol. 186: 6501-6507 [Abstract] [Full Text]  
• Lorenzana, L. M., Perez-Redondo, R., Santamarta, I., Martin, J. F., Liras, P. (2004). Two Oligopeptide-Permease-Encoding Genes in the Clavulanic Acid Cluster of Streptomyces clavuligerus Are Essential for Production of the {beta}-Lactamase Inhibitor. J. Bacteriol. 186: 3431-3438 [Abstract] [Full Text]  
• Jensen, S. E., Paradkar, A. S., Mosher, R. H., Anders, C., Beatty, P. H., Brumlik, M. J., Griffin, A., Barton, B. (2004). Five Additional Genes Are Involved in Clavulanic Acid Biosynthesis in Streptomyces clavuligerus. Antimicrob. Agents Chemother. 48: 192-202 [Abstract] [Full Text]